Logo for CyanoCapture

Meet an Unreasonable Venture

CyanoCapture

Bringing affordable carbon capture to emitting industries worldwide.

Photo of David Kim

David Kim

Founder & CEO at CyanoCapture

More about David »
Employees 6–20
Headquarters United Kingdom
Around 27% of essential drugs on the FDA list are categorised as 'at risk' due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the world's fastest carbon-negative cell to synthesise drugs like insulin at lower cost and address this problem. The award winning technology using the world's fastest photosynthetic cell won the Elon Musk's XPRIZE 2021.

Notable Achievements

  • Raised $4.49M in equity financing from VCs and angels and a further $5M in non-dilutive prizes.
  • Secured $27m in LOIs and pre-orders for non-Pharma grade insulin.
  • Won Elon Musk's XPRIZE 2021 + another $4million from international prizes/grants.

Currently Operating in One Region

Work at CyanoCapture

Posted August 13, 2025

Protein Purification Scientist

Oxford, UK

View Listing »

More Ventures in Energy & Environment

Get the Unreasonable Newsletter

Get monthly updates on CyanoCapture and all of the other ventures working to solve global challenges.

Read our Privacy Policy.